Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies-Reference-Cited by-同舟云学术

Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies

Published:2018-05-10 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Storebø Ole Jakob¹²³,Pedersen Nadia²,Ramstad Erica¹²,Kielsholm Maja Laerke²,Nielsen Signe Sofie²,Krogh Helle B¹²,Moreira-Maia Carlos R⁴,Magnusson Frederik L²,Holmskov Mathilde²,Gerner Trine²,Skoog Maria⁵,Rosendal Susanne⁶,Groth Camilla⁷,Gillies Donna⁸,Buch Rasmussen Kirsten²,Gauci Dorothy⁹,Zwi Morris¹⁰,Kirubakaran Richard¹¹,Håkonsen Sasja J¹²,Aagaard Lise¹³,Simonsen Erik²,Gluud Christian¹⁴¹⁵

Affiliation:

1. Region Zealand; Child and Adolescent Psychiatric Department; Birkevaenget 3 Roskilde Denmark 4300

2. Region Zealand Psychiatry; Psychiatric Research Unit; Slagelse Denmark

3. University of Southern Denmark; Department of Psychology, Faculty of Health Science; Campusvej 55 Odense Denmark 5230

4. Federal University of Rio Grande do Sul; Department of Psychiatry; Rua Ramiro Barcelos, 2350-2201A Porto Alegre RS Brazil 90035-003

5. Clinical Studies Sweden - Forum South; Clinical Study Support; Lund Sweden

6. Psychiatric Centre North Zealand; The Capital Region of Denmark Denmark

7. Herlev University Hospital; Pediatric Department; Capital Region Herlev Denmark

8. Sydney NSW Australia

9. Department of Health; Directorate for Health Information and Research; 95 G'Mangia Hill G'Mangia Malta PTA 1313

10. Whittington Health; Islington Child and Adolescent Mental Health Service; 580 Holloway Road London London UK N7 6LB

11. Christian Medical College; Cochrane South Asia, Prof. BV Moses Centre for Evidence-Informed Healthcare and Health Policy; Carman Block II Floor CMC Campus, Bagayam Vellore India 632002

12. Aalborg University; Department of Health Science and Technology; Niels Jernes Vej 14 Aalborg Denmark 9220

13. Havemann Law Firm; Copenhagen Denmark

14. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100

15. Copenhagen University Hospital; Copenhagen Trial Unit, Centre for Clinical Intervention Research; Copenhagen Denmark

Publisher

Wiley

Subject

Pharmacology (medical)

Reference883 articles.

1. Abali O Mukaddes NM Methylphenidate induced hallucinations: case report Klinik Psikofarmakoloji Bülteni [Bulletin of Clinical Psychopharmacology] 2007 195 7

2. Use of methylphenidate for attention-deficit-hyperactivity disorder in childhood;Abbas;Developmental Medicine and Child Neurology,2006

3. Acetyl-L-carnitine as an adjunctive therapy in the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a placebo-controlled trial;Abbasi;Child Psychiatry and Human Development,2011

4. Explosive outbursts associated with methylphenidate;Adrian;Journal of the American Academy of Child and Adolescent Psychiatry,2001

5. Combination of atomoxetine and methylphenidate in attention deficit/hyperactivity disorder: a case report;Agarwal;Journal of the Canadian Academy of Child and Adolescent Psychiatry,2008

Cited by 241 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing spatial memory and pattern separation: Long-term effects of stimulant treatment in individuals with ADHD;Behavioural Brain Research;2024-10

2. Should methylphenidate be included in the WHO model lists of essential medicines?;European Child & Adolescent Psychiatry;2024-09-12

3. How can (or could) biology inform more effective parenting interventions for childhood aggression?;Aggression and Violent Behavior;2024-09

4. Tamoxifen for adults with hepatocellular carcinoma;Cochrane Database of Systematic Reviews;2024-08-12

5. Contributions of network structure, chemoarchitecture and diagnostic categories to transitions between cognitive topographies;Nature Biomedical Engineering;2024-08-05